Sorafenib tosylate

Sorafenib tosylate
Product Description

Sorafenib tosylate (CAS No.: 475207-59-1) Indications: For the treatment of patients with advanced renal cell carcinoma (RCC). For the treatment of patients with unresectable hepatocellular carcinoma (HCC). For the treatment of patients with locally recurrent or metastatic, progressive, differentiated thyroid carcinoma (DTC) that is refractory to radioactive iodine treatment.

KINHOO PHARMACEUTICAL CO.,LTD

  • CN
  • 2017
    On CPHI since
  • 500 - 999
    Employees
Company types
Pharmaceutical company
Specifications
  • CAS Registry Number
    475207-59-1
  • Supplied from
    China

KINHOO PHARMACEUTICAL CO.,LTD

  • CN
  • 2017
    On CPHI since
  • 500 - 999
    Employees
Company types
Pharmaceutical company

More Products from KINHOO PHARMACEUTICAL CO.,LTD (4)

  • Vardenafil hydrochloride

    Product Vardenafil hydrochloride

    Vardenafil hydrochloride (CAS No.: 330808-88-3)Indications: For the treatment of erectile dysfunction.

  • Lenvatinib mesylate

    Product Lenvatinib mesylate

    Lenvatinib mesylate (CAS No.: 857890-39-2)Indications: For the first-line treatment of patients with unresectable hepatocellular carcinoma (HCC). For the treatment of adult patients with locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid carcinoma (D...
  • Ibuprofen arginine

    Product Ibuprofen arginine

    Ibuprofen arginine (CAS No.: 57469-82-6)Indications: For relief of toothache, dysmenorrhea, pain caused by injury (e.g., athletic injuries), joint and ligament pain, back pain, headache, and fever caused by influenza.

  • Ferrous succinate

    Product Ferrous succinate

    Indications: For the prevention and treatment of Iron Deficiency Anemia (IDA).